发明名称 Method for purifying protein
摘要 The present invention relates to protein purification. More particularly, a method for directly recovering an objective protein from a protein composition and purifying a protein with a desired quality in a rapid and efficient manner is provided. Further, a rapid purification method capable of efficiently removing impurities included in the protein composition is provided. Therefore, compared to the conventional purification methods, quality and yield of the protein can be remarkably improved.
申请公布号 US9487566(B2) 申请公布日期 2016.11.08
申请号 US201214129677 申请日期 2012.06.28
申请人 KYOWA HAKKO KIRIN CO., LTD 发明人 Sugihara Tsutomu;Isoda Tomoko;Taniguchi Yuya;Nomura Hidetaka;Suzawa Toshiyuki
分类号 C07K1/18;C07K14/47;C07K14/81;C07K1/16 主分类号 C07K1/18
代理机构 Sughrue Mion, PLLC 代理人 Sughrue Mion, PLLC
主权项 1. A method for purifying antithrombin, comprising a first chromatographic process including the following processes of (a) to (c): (a) a process of contacting a composition comprising the antithrombin and impurities comprising sialidase with an anion exchange carrier so that the antithrombin and the impurities are adsorbed to the anion exchange carrier; (b) a process of washing the anion exchange carrier to which the antithrombin and the impurities are adsorbed using a first buffer weakening affinity of the impurities for the anion exchange carrier so as to remove the impurities and to inhibit the degradation of sialic acids by inhibiting the activity of sialidase, said first buffer containing 0.1 to 1 mol/L of glycine so as to remove the impurities, and said first buffer being one or more selected from the group consisting of phosphate, citrate, acetate, succinate, maleate, borate, Tris, HEPES, MES, PIPES, MOPS, TES, and Tricine; and (c) a process of eluting the antithrombin from the anion exchange carrier by using a second buffer which is one or more selected from the group consisting of phosphate, citrate, acetate, succinate, maleate, borate, Tris, HEPES, MES, PIPES, MOPS, TES, and Tricine so as to purify antithrombin in which the number of bound sialic acids is 70% or more of the maximum number to be added, wherein the maximum number to be added is 8 mol/mol for Antithrombin α form or 6 mol/mol for Antithrombin β form.
地址 Tokyo JP